| |
Soft tissue tumors of the abdominal wall that are known for their
aggressive biological behavior include soft tissue sarcomas (STS),
desmoid tumors, and dermatofibrosarcoma protuberans (DFSP). Desmoid
tumors, also termed aggressive fibromatosis, are rare (0.03% of
all neoplasms) mesenchymal tumors characterized by proliferation
of fibroblastic cells and abundant collagen fibers that arise from
fascial or musculoaponeurotic structures. Although these tumors
can occur at any age, desmoid tumors occur most often in postpartum
women, with peak prevalence in patients between 20 and 30 years
of age, and in patients with scars due to abdominal surgery. Desmoid
tumors may occur as sporadically or in association with Gardner
Syndrome (29% incidence) or familial adenomatous polyposis (3.2-32%
incidence). Although the pathogenesis of desmoid tumors remains
unknown, various factors are strongly associated with their development
including previous trauma—often surgical, hormonal factors,
or genetic disorders. The preponderance of cases affliciting young
women during or after pregnancy, tumor development following exposure
to oral contraceptives, and tumor regression during menopause and
after tamoxifen treatment are all evidence for the suspected endocrine/hormonal
basis for desmoid tumors.
Desmoid tumors are classified as extra-abdominal, intra-abdominal,
or located within the abdominal wall. Abdominal wall desmoid tumors
arise most commonly from the aponeurosis of the rectus abdominus
muscle with out without intraabdominal extension. Intra-abdominal
desmoids arise from the mesentery, retroperitoneum, or pelvic wall.
The most common site for mesenteric desmoid tumors is at the base
of the small bowel mesentery. Extra-abdominal tumors typically occur
in the shoulder, chest wall, thigh, inguinal region, and back. Clinical
symptoms are masked by the slow growth of the tumor and depend on
the site to tumor involvement. Desmoid tumors can cause symptoms
by infiltration, compression, displacement of intestinal, genitourinary,
vascular, or neuronal tissue (e.g. intestinal obstruction, hydronephrosis).
Grossly, desmoid tumors vary in size from 1 to 15 cm in greater
diameter. In general, they are unicentric, infiltrative lesions
with poorly defined borders. However, discrete, well-circumscribed
tumors also occur. These masses are relatively avascular, firm,
and unencapsulated with coarse white trabeculae that simulate scar
tissue. On histological analysis, desmoid tumors are benign fibrous
neoplasms consisting of elongated spindle-shaped cells separated
by dense bands of collagen.
Radiological investigations of desmoid tumors, typically CT or
MRI, should be undertaken to define the extent of the tumor, the
relationship to local structures, and complications such as hydronephrosis
and small bowel obstruction, especially prior to surgical resection.
Desmoid tumors have a similar attenuation to muscle on contrast-enhanced
CT images. However, CT cannot distinguish a desmoid tumor from similar
soft tissue tumors, making histological diagnosis necessary. MRI
enables better tissue characterization of desmoid tumors by demonstrating
intratumoral areas of low signal intensity on all pulse sequences.
The low signal intensity is due to the presence of abundant collagen
within the lesion. Desmoid tumors appear as low-signal intensity
masses in a background of high-signal intensity fat on T1-weighted
MR images. These tumors have variable signal intensity on T2-weighted
MR images. In mature desmoids, areas of abundant fibrosis results
in low signal intensity on T2-weighted images. Longstanding tumors
are low in signal intensity on T1 and T2-weighted MR images and
enhance only minimally after intravenous gadolinium chelate. In
the acute phase, tumors may have regions of high signal intensity
on T2-weighted images that also show heterogeneous increased enhancement.
Tumor recurrence is a frequent finding after surgery and is easily
detected using MRI.
Despite their benign histologic appearance and negligible metastatic
potential, the propensity of desmoid tumors for local infiltration
is significant in terms of deformity, morbidity and mortality resulting
from pressure effects and potential obstruction of vital structures
and organs. Desmoid tumors are treated with surgical resection.
Since these tumors have a high rate of recurrence, adjunct radiation
therapy is also recommended. Radiation therapy may be used as a
treatment of recurrent disease or as primary therapy in cases with
extremely complicated surgical resections. Pharmacologic therapy
with antiestrogens and prostaglandin inhibitors may also be used.
In cases of recurrent extra-abdominal desmoid tumors in which surgery
is contraindicated or in cases of recurrence, a chemotherapeutic
regimen of doxorubicin, dacarbazine, and carboplatin may be effective.
References:
- Semelka, Richard. Abdominal-Pelvic MRI. New York: Wiley-Liss
Inc, 2002. pp. 659-660, 939, 941.
- Trovato MJ and RA Schwartz. Desmoid Tumor. (2003).
eMedicine
(04/19/04).
- Shields CJ, Winter DC, et al. Desmoid Tumors. European
Journal of Surgical Oncology. 2001; 27: 701-706.
- Stojadinovic A, Hoos A, et al. Soft Tissue Tumors of the
Abdominal Wall. Archives of Surgery. 2001; 136: 70-79.
- Vandevenne JE, De Schepper AM, et al. New Concepts in Understanding
Evolution of Desmoid Tumors: MR Imaging of 30 Lesions. European
Radiology. 1997; 7: 1013-1019.
- Casillas J, Sais GJ, Greve JL, et al. Imaging of Intra-
and Extraabdominal Desmoid Tumors. RadioGraphics. 1991; 11:
959-968.
|
|